Accurate Identification of Klebsiella variicola by MALDI-TOF Mass Spectrometry in Clinical Microbiology Laboratories

被引:7
|
作者
Ohama, Yuki [1 ]
Nomura, Yusuke [1 ]
Mizoguchi, Miyuki [1 ]
Higurashi, Yoshimi [1 ]
Okamoto, Koh [2 ]
Harada, Sohei [1 ]
机构
[1] Univ Tokyo Hosp, Dept Infect Control & Prevent, Tokyo, Japan
[2] Univ Tokyo Hosp, Dept Infect Dis, Tokyo, Japan
来源
MICROBIOLOGY SPECTRUM | 2022年 / 10卷 / 05期
关键词
Klebsiella pneumoniae; Klebsiella quasipneumoniae; Klebsiella variicola; MALDI-TOF; PCR;
D O I
10.1128/spectrum.02844-22
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Recent widespread use of bacterial whole-genome sequencing analysis has resulted in the proposal of novel bacterial species and reclassification of taxonomy. Accurate methods for identification of bacterial species in clinical microbiology laboratories are essential to accumulate information on the clinical characteristics of each bacterial species. Klebsiella variicola is a member of the Klebsiella pneumoniae complex, and its association with human infections has been increasingly recognized, but accurate identification methods approved for use in clinical microbiology laboratories have been limited thus far. Klebsiella variicola is a pathogen that is increasingly recognized as being associated with human infections, but the methods available to clinical microbiology laboratories for accurate identification are limited. In this study, we assessed the accuracy of identification of K. variicola by matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry using genetic identification with multiplex PCR as the reference method. Antimicrobial susceptibilities and virulence of K. variicola strains were also investigated. Fifty-five Klebsiella pneumoniae, 26 K. variicola, and 2 Klebsiella quasipneumoniae clinical strains were used for evaluation. Both MALDI Biotyper with library version 9 and Klebsiella MALDI TypeR, a web-based species identification tool using MALDI-TOF data, accurately identified all K. variicola strains. In addition, two strains of K. quasipneumoniae were accurately identified with Klebsiella MALDI TypeR. Whole-genome sequencing confirmed the accurate identification to the subspecies level by Klebsiella MALDI TypeR for four strains (two strains each of K. variicola subsp. variicola and K. quasipneumoniae subsp. similipneumoniae). While 13 strains, 3 strains, and 1 strain of K. pneumoniae showed nonsusceptibility to ampicillin-sulbactam, ceftriaxone, and meropenem, respectively, all strains of K. variicola were susceptible to all tested antimicrobial agents. Although two K. variicola strains were positive for the string test, no K. variicola strains harbored any of the genes associated with hypervirulence of K. pneumoniae. Accurate identification of the K. pneumoniae complex, including K. variicola, by MALDI-TOF in clinical microbiology laboratories is expected to clarify the clinical characteristics of each species in the future. IMPORTANCE Recent widespread use of bacterial whole-genome sequencing analysis has resulted in the proposal of novel bacterial species and reclassification of taxonomy. Accurate methods for identification of bacterial species in clinical microbiology laboratories are essential to accumulate information on the clinical characteristics of each bacterial species. Klebsiella variicola is a member of the Klebsiella pneumoniae complex, and its association with human infections has been increasingly recognized, but accurate identification methods approved for use in clinical microbiology laboratories have been limited thus far. The findings of the present study suggest that K. variicola can be accurately identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry using updated library or web-based identification tools. Accurate identification will promote exploration of clinical characteristics of K. variicola.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Application of MALDI-TOF mass spectrometry in screening and diagnostic research
    Pusch, W
    Kostrzewa, M
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (20) : 2577 - 2591
  • [42] Imaging of methamphetamine incorporated into hair by MALDI-TOF mass spectrometry
    Akihiro Miki
    Munehiro Katagi
    Noriaki Shima
    Hiroe Kamata
    Michiaki Tatsuno
    Toyofumi Nakanishi
    Hitoshi Tsuchihashi
    Takayuki Takubo
    Koichi Suzuki
    Forensic Toxicology, 2011, 29 : 111 - 116
  • [43] Susceptibility Testing of Bacteria Using Maldi-Tof Mass Spectrometry
    Burckhardt, Irene
    Zimmermann, Stefan
    FRONTIERS IN MICROBIOLOGY, 2018, 9
  • [44] MALDI-TOF Mass Spectrometry Applications for Food Fraud Detection
    Zambonin, Carlo
    APPLIED SCIENCES-BASEL, 2021, 11 (08):
  • [45] Characterization of cyclic β-glucans of Bradyrhizobium by MALDI-TOF mass spectrometry
    Choma, Adam
    Komaniecka, Iwona
    CARBOHYDRATE RESEARCH, 2011, 346 (13) : 1945 - 1950
  • [46] Imaging of methamphetamine incorporated into hair by MALDI-TOF mass spectrometry
    Miki, Akihiro
    Katagi, Munehiro
    Shima, Noriaki
    Kamata, Hiroe
    Tatsuno, Michiaki
    Nakanishi, Toyofumi
    Tsuchihashi, Hitoshi
    Takubo, Takayuki
    Suzuki, Koichi
    FORENSIC TOXICOLOGY, 2011, 29 (02) : 111 - 116
  • [47] Investigating quantitation of phosphorylation using MALDI-TOF mass spectrometry
    Parker, Laurie
    Engel-Hall, Aaron
    Drew, Kevin
    Steinhardt, George
    Helseth, Donald L., Jr.
    Jabon, David
    McMurry, Timothy
    Angulo, David S.
    Kron, Stephen J.
    JOURNAL OF MASS SPECTROMETRY, 2008, 43 (04): : 518 - 527
  • [48] MALDI-TOF mass spectrometry for differentiation between Streptococcus pneumoniae and Streptococcus pseudopneumoniae
    van Prehn, Joffrey
    van Veen, Suzanne Q.
    Schelfaut, Jacqueline J. G.
    Wessels, Els
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2016, 85 (01) : 9 - 11
  • [49] Genotyping of thrombotic risk factors by MALDI-TOF mass spectrometry
    Humeny, A
    Bonk, T
    Berkholz, A
    Wildt, L
    Becker, CM
    CLINICAL BIOCHEMISTRY, 2001, 34 (07) : 531 - 536
  • [50] MALDI-TOF mass spectrometry-based SNP genotyping
    Pusch, W
    Wurmbach, JH
    Thiele, H
    Kostrzewa, M
    PHARMACOGENOMICS, 2002, 3 (04) : 537 - 548